Edition:
United Kingdom

Omeros Corp (OMER.OQ)

OMER.OQ on NASDAQ Stock Exchange Global Market

24.99USD
8:57pm BST
Change (% chg)

$0.68 (+2.80%)
Prev Close
$24.31
Open
$24.28
Day's High
$25.00
Day's Low
$24.12
Volume
211,969
Avg. Vol
184,311
52-wk High
$26.96
52-wk Low
$8.36

Chart for

About

Omeros Corporation is a commercial-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases and disorders of the central nervous system. The... (more)

Overall

Beta: 3.62
Market Cap(Mil.): $1,019.17
Shares Outstanding(Mil.): 47.45
Dividend: --
Yield (%): --

Financials

  OMER.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.46 -- --
ROI: -192.07 1.78 14.61
ROE: -- 3.27 16.33

BRIEF-Omeros Says Entered Into Settlement Agreement And Consent Judgment With Lupin Ltd and unit Lupin Pharmaceuticals - SEC Filing

* OMEROS SAYS ENTERED INTO SETTLEMENT AGREEMENT AND CONSENT JUDGMENT WITH LUPIN LTD, SUBSIDIARY LUPIN PHARMACEUTICALS - SEC FILING

24 May 2018

BRIEF-FDA Grants Breakthrough Therapy Designation To Omeros' Masp-2 Inhibitor Oms721

* FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION TO OMEROS’ MASP-2 INHIBITOR OMS721 FOR THE TREATMENT OF HIGH-RISK HEMATOPOIETIC STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY

26 Apr 2018

BRIEF-Omeros Announces Amendment Of Credit Facility

* AMENDED ITS EXISTING CREDIT FACILITY WITH CERTAIN AFFILIATES OF CRG LP

11 Apr 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $142.88 +0.90
Novartis AG (NOVN.S) CHF81.88 -0.06
Pfizer Inc. (PFE.N) $44.06 +0.31
Roche Holding Ltd. (ROG.S) CHF235.15 +0.10
Roche Holding Ltd. (RO.S) CHF235.40 -1.20
Merck & Co., Inc. (MRK.N) $71.10 +0.32
Bayer AG (BAYGn.DE) €76.52 +0.70
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €74.50 -0.17
Eli Lilly And Co (LLY.N) $106.33 +0.26

Earnings vs. Estimates